The behavioral health industry experienced a marked increase in False Claims Act settlements during fiscal year 2020, reflecting heightened federal scrutiny and enforcement activity targeting substance use disorder treatment providers and mental health organizations amid expanding government funding and regulatory attention directed toward the sector. Bass, Berry & Sims’ annual Healthcare Fraud & Abuse Review documented this enforcement surge, with numerous behavioral health providers resolving allegations related to inflating bills for services rendered, submitting claims for medically unnecessary treatment, and other billing irregularities that generated substantial financial recoveries for the government while signaling elevated compliance risk for organizations operating in behavioral health treatment markets.
The enforcement trend confirms perspectives that industry sources have shared with Behavioral Health Business throughout recent months: as federal attention and funding for behavioral health services has increased through expanded Medicaid coverage, mental health parity enforcement, opioid crisis response initiatives, and pandemic-related appropriations, providers face corresponding intensification of government oversight, audit activity, and investigation that elevates vulnerability to enforcement actions compared to periods when behavioral health received less policy prioritization and funding allocation. This dynamic reflects a consistent pattern across healthcare sectors where increased government spending generates proportional fraud prevention and detection efforts as agencies work to protect program integrity and ensure that expanded appropriations fund legitimate services rather than enriching fraudulent providers.
Qui Tam Whistleblower Lawsuits Drive Enforcement Activity
Fiscal year 2020 saw 672 qui tam whistleblower lawsuits filed under the False Claims Act across all healthcare sectors according to the Bass, Berry & Sims analysis, with these private enforcement actions continuing to represent the dominant mechanism through which alleged fraud comes to government attention. Qui tam provisions enable private individuals, typically current or former employees, to file lawsuits on the government’s behalf alleging that healthcare providers have submitted fraudulent claims to Medicare, Medicaid, or other federal healthcare programs, with successful whistleblowers receiving portions of any financial recoveries ranging from 15% to 30% depending on whether the government intervenes in the litigation.
The financial incentives associated with whistleblowing prove substantial, with approximately $309 million paid to whistleblowers across all healthcare sectors during fiscal year 2020 as their shares of total recoveries. These reward payments create powerful motivations for employees who observe billing practices, documentation standards, or clinical decision-making they perceive as potentially fraudulent to report concerns through False Claims Act litigation rather than internal compliance channels, particularly when whistleblowers feel that organizations have not adequately addressed their concerns or when employment relationships have deteriorated creating adversarial dynamics between staff and management.
Asher Funk, a shareholder at law firm Polsinelli who previously discussed rising behavioral health enforcement actions, characterized the incentives given to private whistleblowers as absolutely staggering, emphasizing that the opportunity for individuals within organizations to observe what they perceive as fraud against the government, bring legal actions in the government’s name, and ultimately receive substantial portions of any financial recovery creates dynamics that healthcare providers cannot underestimate. The qui tam mechanism essentially deputizes employees as fraud detection agents with significant financial stakes in identifying and reporting potential violations, fundamentally altering workplace dynamics and creating latent compliance risks in every billing decision, documentation practice, and clinical judgment that could potentially be characterized as fraudulent by motivated whistleblowers.
Behavioral Health Settlements Reflect Common Violation Patterns
Several significant behavioral health False Claims Act settlements during fiscal year 2020 illustrate the types of allegations generating enforcement activity and the financial exposure that providers face when billing practices come under government scrutiny. Preferred Family Healthcare agreed to pay $6.5 million resolving allegations, while Tree of Life Inc. settled for $1.65 million and East Tennessee Recovery paid $530,000, with many settlements addressing claims that providers inflated bills for services rendered through upcoding, billing for services not provided, or mischaracterizing the nature or intensity of care delivered to patients.
The fiscal year’s largest behavioral health settlement involved Universal Health Services, UHS of Delaware, and an affiliated facility agreeing to pay $122 million resolving numerous False Claims Act allegations, representing one of the most substantial behavioral health enforcement actions in recent history. While settlement agreements typically include no admission of liability and defendants often characterize payments as business decisions avoiding protracted litigation costs rather than acknowledgments of wrongdoing, the scale of financial recoveries demonstrates the serious consequences that providers face when billing practices generate government investigations regardless of whether intentional fraud occurred.
Common behavioral health fraud allegations involve billing for services not rendered, submitting claims for medically unnecessary treatment determined by financial rather than clinical considerations, upcoding by billing higher-level service codes than documentation supports, unbundling by separately billing component services that should be billed together at lower aggregate rates, providing kickbacks or inducements for patient referrals, and billing for services provided by unlicensed or inadequately supervised staff. These violation patterns reflect both the complexity of healthcare billing regulations that providers may inadvertently violate and intentional schemes where organizations systematically manipulate billing to maximize revenue regardless of whether services meet medical necessity criteria or comply with coverage requirements.
Financial Pressures Create Settlement Incentives
Many providers facing government audits and investigations ultimately settle allegations rather than contesting claims through protracted litigation, with financial considerations driving settlement decisions regardless of whether providers believe they committed violations warranting penalties. The costs of defending False Claims Act litigation including attorney fees, expert witnesses, document production, executive time diverted from operations, and business disruption can equal or exceed potential settlement amounts, creating rational economic incentives to resolve matters even when providers maintain they operated appropriately and could potentially prevail at trial.
Additionally, the False Claims Act’s treble damages provisions authorizing the government to recover three times its actual damages plus civil penalties ranging from $11,665 to $23,331 per false claim create catastrophic financial exposure if providers lose at trial, making settlement attractive as risk mitigation even when providers assess their litigation prospects favorably. The asymmetric risk profile where settlement caps financial exposure at negotiated amounts while adverse trial verdicts could generate existential liabilities encourages resolution rather than vindication through contested proceedings.
Organizations must also consider reputational consequences from publicized fraud investigations and litigation regardless of ultimate outcomes, with negative media coverage, payer scrutiny, and referral source concerns potentially damaging operations more substantially than the direct costs of defending allegations. For publicly traded companies or private equity-backed platforms, fraud allegations can affect stock prices, investor confidence, acquisition valuations, and access to capital markets, creating stakeholder pressures to resolve matters quickly rather than allowing uncertainties to persist through multi-year litigation timelines.
Compliance Programs Represent Essential Risk Mitigation
The enforcement environment underscores the critical importance of comprehensive compliance programs that behavioral health providers must implement and maintain to prevent violations, detect problems early enabling self-correction before government intervention, and demonstrate good faith efforts to operate lawfully that can mitigate penalties if violations occur. Effective compliance programs encompass written policies and procedures addressing billing practices, medical necessity determinations, documentation requirements, and regulatory obligations; regular training ensuring that clinical and administrative staff understand compliance expectations; internal auditing identifying billing errors or problematic patterns requiring correction; mechanisms enabling employees to report concerns confidentially without retaliation; and prompt investigation and remediation of identified problems.
Funk emphasized that providers must make employees with complaints feel heard, recognizing that many qui tam whistleblower cases originate when staff members report concerns internally but perceive that organizations ignored or dismissed their complaints, prompting external reporting through False Claims Act litigation. Organizations that create cultures where compliance concerns receive serious attention, investigation, and response can potentially prevent whistleblower litigation by addressing problems internally and demonstrating to concerned employees that management takes compliance seriously rather than prioritizing revenue over regulatory adherence.
Compliance programs should specifically address the billing practices and clinical decision-making patterns that commonly generate behavioral health fraud allegations, including ensuring that medical necessity determinations reflect clinical judgment rather than financial considerations, that documentation contemporaneously supports billed services with sufficient detail demonstrating that care was provided as claimed, that staff credentials and supervision meet requirements for the services billed under their credentials, and that length of stay and treatment intensity decisions align with patient clinical needs rather than maximizing reimbursement.
Non-Qui Tam Civil Fraud Litigation Also Increased
Beyond whistleblower-initiated qui tam cases, fiscal year 2020 saw 250 new non-qui tam civil fraud lawsuits within healthcare representing government-initiated enforcement actions, a jump of more than 100 such suits compared to fiscal year 2019. This increase suggests that government agencies are dedicating enhanced resources to fraud detection and investigation independent of whistleblower complaints, utilizing data analytics, provider audits, and proactive enforcement strategies identifying potential fraud through statistical outliers, billing pattern analysis, and targeted reviews of high-risk provider categories or geographic areas.
The combination of increased qui tam whistleblower litigation and expanded government-initiated enforcement creates a multi-front compliance environment where behavioral health providers face elevated risk from both internal whistleblowers and external government scrutiny. This dual exposure requires organizations to maintain vigilance across all operational aspects that could generate fraud allegations while recognizing that even well-intentioned providers can face investigations triggered by employee complaints, statistical anomalies, or audit selection processes that may not reflect actual wrongdoing but nonetheless require expensive defense and potential financial resolution.
Total Healthcare Fraud Recoveries Remain Substantial
Overall healthcare organizations paid $1.8 billion in False Claims Act recoveries during fiscal year 2020 ended September 30, representing a 44% decrease from the $2.6 billion recovered during fiscal year 2019. While the year-over-year decline might suggest reduced enforcement activity, the absolute recovery amounts remain substantial and the decrease likely reflects the timing of major settlements rather than fundamental enforcement policy changes, with individual mega-settlements in particular fiscal years creating volatility in annual recovery totals that don’t necessarily indicate trend directionality.
Behavioral health providers should interpret the enforcement landscape as presenting elevated and sustained compliance risk requiring ongoing investment in prevention, detection, and remediation capabilities rather than assuming that any particular year’s statistics indicate reduced government attention or enforcement priorities. The fundamental dynamics driving behavioral health fraud enforcement including expanded government funding, increased policy focus, complex billing regulations, and powerful whistleblower financial incentives will persist regardless of year-to-year fluctuations in settlement totals, requiring providers to maintain compliance as a core organizational priority comparable to clinical quality and financial performance rather than treating it as a peripheral concern or administrative burden.
As federal agencies continue prioritizing healthcare fraud enforcement and behavioral health receives growing government funding and policy attention, providers must recognize that compliance excellence represents not merely regulatory obligation but essential business imperative protecting organizations from potentially catastrophic legal and financial consequences that fraud allegations and enforcement actions can generate.
